ACADIA Pharmaceuticals Inc (ACAD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)

ACAD 24.87

-0.6%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (242)	2/21/2006 12:26:10 PM
From: scaram(o)uche	of 588

CB1R antagonist with acomplia just now "approvable"..... delayed, but conceptually ok at FDA...... the best scenario for building a little market cap under this new program, maybe 12 months or so? >> potent and selective for the CB1 receptor, active following oral dosing in preclinical models, and well tolerated at high doses << Nice update.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next